Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 16, 2014

View Archived Issues

Regeneron launches new human genetics initiative via new subsidiary

Portola Pharmaceuticals forms second collaboration with BMS and Pfizer

Regeneron and Bayer enter agreement to develop combination therapy for wet AMD

Crealta Pharmaceuticals completes acquisition of Savient Pharmaceuticals

BioMarin to develop factor VIII gene therapy candidate BMN-270 for hemophilia A

Synthon Biopharmaceuticals prepares for phase I study of SYD-985

Tekmira initiates dosing in phase I trial of anti-Ebola viral therapeutic

Engineered human liver tissues may be an alternate means of generating hepatitis models

NS-018 suppresses CFU-GM colony formation by BMMNCs from high-risk MDS patients

Radius Health reports topline data from phase II abaloparatide study

FDA clears IND for the CHART-2 trial in heart failure

Immunomedics begins phase III trial of yttrium Y 90 clivatuzumab tetraxetan

Synta Pharmaceuticals launches clinical trials evaluating ganetespib in cancer

Bayer reintroduces Diane-35 in France

First patient treated in Neuralstem China stem cell trial in ischemic stroke patients

AG-348 activates mutant PKLR enzymes in patient-derived red cells

AbbVie begins phase III study of veliparib in triple-negative breast cancer

Astellas Pharma reports data from phase III trials of seasonal flu vaccine

IND application filed for GR-MD-02 in metastatic melanoma

Jazz Pharmaceuticals looks towards 2014 with pipeline overview

FDA committee recommends approval of Merck & Co.'s investigational antiplatelet medicine

Italian and Belgian team patents novel anticancer compounds

AstraZeneca identifies BACE1 inhibitors

Positive allosteric modulators of mGlu2 receptors reported in BMS patent

Chinese researchers report discovery of novel DPP IV inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...